Kolexia
Parent Damien Pharmacien
Parent Damien
Pharmacien
Institut Godinot
Reims, France
66 Activités
257 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Métastase tumorale Tumeur du sein de l'homme Tumeurs du poumon Tumeurs du sein triple-négatives Thromboembolie Thromboembolisme veineux Épuisement professionnel Stress professionnel

Collaborateurs

Voir plus
Rey Jean-Baptiste
Rey Jean-Baptiste
Clinique Medico Chirurgicale St Faron, Mareuil-lès-Meaux, France
Robain Mathieu
Robain Mathieu
Federation Nationale Des Centres De Lutte Contre Le Cancer, Paris, France
Savoye Aude-Marie
Savoye Aude-Marie
Institut Godinot, Reims, France
Bouche Olivier
Bouche Olivier
Hôpital Robert-Debré Reims, Reims, France

Industries

Voir plus
MSD
2 collaboration(s)
Dernière en 2022
Lilly
2 collaboration(s)
Dernière en 2023
Gilead
2 collaboration(s)
Dernière en 2023
Leo Pharma
1 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC): Epidemiological Strategy and Medical Economic (ESME) Research Program / Academic Real World Data Platform: Evolution of the Therapeutic Care in Lung Cancer in France Since 2015
Essai Clinique (BMS)   15 décembre 2023
Damien Parent - Facebook
Facebook   04 septembre 2023
ESME-MBC: Epidemiological Strategy and Medical Economic (ESME) Research Program / Academic Real World Data Platform: Evolution of the Therapeutic Care in Metastatic Breast Cancer Across the French Comprehensive Cancer Centers From 2008
Essai Clinique (Seagen)   16 mars 2023
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database.
BMC medicine   08 mars 2023
Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?
BMC cancer   25 novembre 2022
250P Association between progression free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: Evidence from the ESME real-world database
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Real-world outcomes for patients with metastatic non-small cell lung cancer according to first-line treatment
SI: 69/S1 - EPICLIN 2021   01 juin 2021
Outcome beyond third-line chemotherapy for metastatic triple-negative breast cancer in the French ESME program.
Breast (Edinburgh, Scotland)   30 janvier 2021
Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC Study.
Anticancer research   05 août 2020
Assessment of the efficacy of successive endocrine therapies in hormone receptor-positive and HER2-negative metastatic breast cancer: a real-life multicentre national study.
European journal of cancer (Oxford, England : 1990)   19 juillet 2019